Author Correction: The Molecular Tumor Board Portal Supports Clinical Decisions and Automated Reporting for Precision Oncology

Overview

Journal Nat Cancer

Specialty Oncology

Date 2022 Apr 22

PMID 35449310

Authors

David Tamborero

Rodrigo Dienstmann

Maan Haj Rachid

Jorrit Boekel

Adria Lopez-Fernandez

Markus Jonsson

Ali Razzak

Irene Brana

Luigi De Petris

Jeffrey Yachnin

Richard D Baird

Yohann Loriot

Christophe Massard

Patricia Martin-Romano

Frans Opdam

Richard F Schlenk

Claudio Vernieri

Michele Masucci

Xenia Villalobos

Elena Chavarria

Judith Balmana

Giovanni Apolone

Carlos Caldas

Jonas Bergh

Ingemar Ernberg

Stefan Frohling

Elena Garralda

Claes Karlsson

Josep Tabernero

Emile Voest

Jordi Rodon

Janne Lehtio

Affiliations

Soon will be listed here.

Citing Articles

Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.

Roos-Mattila M, Kallio P, Luck T, Polso M, Kumari R, Mikkonen P Commun Biol. 2024; 7(1):1355.

PMID: 39427059 PMC: 11490566. DOI: 10.1038/s42003-024-07004-9.

[The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)].

Metzger P, Boerries M Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024; 67(6):668-675.

PMID: 38739266 PMC: 11166753. DOI: 10.1007/s00103-024-03886-6.

Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients.

Falcone R, Lombardi P, Filetti M, Fabi A, Altamura V, Scambia G Curr Oncol. 2023; 30(2):2501-2509.

PMID: 36826152 PMC: 9954949. DOI: 10.3390/curroncol30020191.